Polymedco
Polymedco is a US-based medical device company founded in 1980 that develops clinical diagnostic test kits for early detection of colorectal cancer and cardiac events, serving healthcare systems, reference laboratories, and emergency departments with its OC-Auto FIT and PATHFAST analyzer platforms.
- Company typePrivate
- Founded1980
- HeadquartersCortlandt Manor, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Polymedco does
Polymedco is a US-based medical device company founded in 1980 and headquartered in Cortlandt Manor, New York, that develops and commercializes clinical diagnostic test kits for the early detection of life-threatening diseases. The company primarily serves healthcare systems, hospitals, integrated delivery networks, reference laboratories, payors, and emergency departments with two principal product franchises: OC-Auto FIT, an automated fecal immunochemical testing (FIT) platform for colorectal cancer screening, and PATHFAST, a point-of-care cardiac biomarker analyzer. Complementing these are OC-Light S FIT (a qualitative strip test), SEDITEN and SEDIMAT ESR readers, and BTA stat for bladder cancer detection. Polymedco is positioned as the #1 automated noninvasive CRC screening tool globally with a Tier 1 US Preventive Services Task Force guideline recommendation, supported by published outcomes including a 43.8% increase in patient compliance, 25.5% reduction in CRC incidence, and 52.4% reduction in cancer mortality in community-based populations.
Polymedco firmographics
Firmographics- Name
- Polymedco
- Legal name
- Polymedco
- Website
- https://polymedco.com
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Polymedco is a US-based medical device company founded in 1980 that develops clinical diagnostic test kits for early detection of colorectal cancer and cardiac events, serving healthcare systems, reference laboratories, and emergency departments with its OC-Auto FIT and PATHFAST analyzer platforms.
- Ownership category
- akta.pro rank
Polymedco industry classification
Industry- Product category
- In Vitro Clinical Diagnostics
- NAICS
- Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE)
- akta.pro secondary industries
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Chemistry, Hematology & Coagulation Testing (Trial Support) (HLAGAEAE)
Keywords
Where Polymedco is headquartered
LocationHeadquarters
- HQ city
- Cortlandt Manor
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Polymedco business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Diagnostic Equipment Sales: Sale of diagnostic analyzers including OC-Auto FIT instruments (Sensor io and Sensor Diana) and PATHFAST benchtop analyzers for clinical laboratory and point-of-care settings.
- Diagnostic Reagents and Consumables: Recurring revenue from sale of test reagents, sample collection devices, and consumables for FIT screening and cardiac biomarker testing on proprietary analyzer platforms.
- Programmatic Services: Customizable programmatic solutions including patient education materials, in-service training, business reviews, and direct-to-patient mailing services to support screening program implementation.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Polymedco product offering
Product offeringCore offering
Polymedco develops, manufactures, and sells clinical diagnostic test kits and analyzers focused on early detection of life-threatening diseases. Its core offerings are the OC-Auto FIT family of automated fecal immunochemical testing analyzers and the OC-Light S FIT strip test for colorectal cancer screening, the PATHFAST benchtop analyzer and hs-cTnI-II assay for point-of-care cardiac biomarker testing, plus ESR readers (SEDITEN, SEDIMAT 15 Plus) and the BTA stat bladder cancer test. The company bundles these products with customizable programmatic screening services including training, patient education, and direct-to-patient outreach for healthcare systems, payors, providers, reference labs, and emergency departments.
Product overview
Polymedco offers a portfolio of diagnostic products focused on early detection of life-threatening diseases, primarily in cancer screening and cardiac biomarker testing. The core product lines include OC-Auto® FIT (automated fecal immunochemical test for colorectal cancer screening) with associated analyzers (OC-Auto Sensor io and OC-Auto Sensor Diana), OC-Light S® FIT (qualitative strip test), and the PATHFAST® Analyzer system for cardiac biomarker testing including the FDA-cleared hs-cTnI-II high-sensitivity troponin test. Additional products include SEDITEN® and SEDIMAT® ESR Readers for erythrocyte sedimentation rate testing, and the BTA stat® Test for bladder cancer detection. The company provides customizable programmatic screening solutions to help health systems increase patient participation and reduce mortality rates.
Differentiator
Problem solved
Functional benefit
Brands
- OC-Auto® FIT: Automated fecal immunochemical test (FIT) for colorectal cancer screening - the #1 automated noninvasive CRC screening tool in the world with Tier 1 guideline recommendation
- PATHFAST®
- OC-Light S® FIT
- SEDITEN® ESR Reader
- SEDIMAT® 15 Plus
- BTA stat® Test
Products and services
- OC-Auto FIT
Quantifiable outcome
- 43.8% increase in patient compliance with CRC screening
- +7 more outcomes
Companies that use Polymedco
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Polymedco technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
Polymedco partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered strategic, standard and flagship.
- CancerXstrategicPolymedco joined CancerX in January 2024, a national oncology innovation initiative aimed at accelerating innovation in cancer detection and diagnosis. Participation in this partnership demonstrates commitment to advancing cancer screening technology and contributing to national screening improvement goals.
- Bio Analytica S.A. (Argentina)standardInternational distribution partner for Polymedco products in Argentina, responsible for local sales, distribution, and customer support of OC-Auto FIT and PATHFAST diagnostic solutions.
- Labimed S.A. (Bolivia, Paraguay, Uruguay)standardDistribution partner covering Bolivia, Paraguay, and Uruguay markets for Polymedco diagnostic products including colorectal cancer screening and cardiac biomarker solutions.
- Ubuntu Med, Ldta. (Brazil)standardExclusive or authorized distribution partner for Polymedco products in Brazil, handling local market penetration and customer relationships for diagnostic testing solutions.
- Biocant Ldta. (Chile)standardAuthorized distributor for Polymedco diagnostic products in Chile, supporting local healthcare providers with access to CRC screening and cardiac biomarker testing solutions.
- Capris Médica (Costa Rica, El Salvador, Guatemala, Panama)standardRegional distribution partner covering Costa Rica, El Salvador, Guatemala, and Panama, providing comprehensive distribution services for Polymedco product portfolio.
- Edomedica S.A. de C.V. and MedPrimex LLC (Mexico)standardDual distribution partners in Mexico market, with Edomedica and MedPrimex providing local sales and distribution coverage for Polymedco diagnostic solutions.
- DIVCOM Labimed S.A. (Peru)standardAuthorized distributor for Polymedco products in Peru, facilitating market access and distribution of screening and diagnostic testing solutions to local healthcare institutions.
- Union for International Cancer Control (UICC) / BBC StoryWorksflagshipPolymedco collaborated with UICC and BBC StoryWorks Commercial Productions on the Rewriting Cancer series, producing a documentary featuring patient story and clinical expert perspectives on OC-Auto FIT screening, contributing to public health awareness and brand positioning.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Polymedco competitors and assessment
Company assessmentBroad incumbents
- Roche Diagnostics: Roche Diagnostics operates the Elecsys hs-cTn and cobas cardiac biomarker platforms, directly competing with PATHFAST in hospital labs. As the global IVD leader, Roche also competes with Polymedco for central lab automation footprint and CRC screening contract wins.
- Hologic: Hologic's diagnostics division focuses on women's health, molecular, and cytology screening, including HPV and STI testing sold to similar healthcare system customers that buy OC-Auto FIT and PATHFAST. While not a direct FIT competitor, Hologic competes for the same hospital and reference lab IVD contracts.
- Beckman Coulter (Danaher): Beckman Coulter is a major IVD incumbent whose Access family of hs-cTnI assays and DxH hematology analyzers compete with PATHFAST cardiac menu and Polymedco's ESR (SEDITEN/SEDIMAT) lines. The company serves the same hospital and reference lab customers as Polymedco.
- Siemens Healthineers: Siemens Healthineers markets the Atellica and ADVIA Centaur cardiac biomarker platforms that compete with PATHFAST in hospital core labs. As a broad IVD incumbent with established enterprise health system contracts, Siemens competes with Polymedco for the same hospital, payor, and reference lab relationships.
- Abbott Diagnostics: Abbott's i-STAT and ARCHITECT platforms provide point-of-care and central lab cardiac biomarker testing, directly competing with PATHFAST in emergency and STAT lab settings. Abbott is a broadly diversified IVD incumbent spanning cardiac, infectious disease, and core lab diagnostics.
Direct peers
- Guardant Health: Guardant Health's Shield blood-based CRC screening test is a direct emerging competitor to OC-Auto FIT for noninvasive CRC screening. Both companies compete for USPSTF inclusion, Medicare coverage, and health system population health contracts.
- Sekisui Diagnostics: Sekisui Diagnostics manufactures fecal immunochemical and occult blood tests for CRC screening, directly competing with OC-Auto FIT and OC-Light S in clinical labs and screening programs. Both companies target the same FIT-based screening market with similar automated analyzer platforms.
- Exact Sciences: Exact Sciences markets Cologuard, the most established non-colonoscopy CRC screening test in the US, competing head-to-head with Polymedco's OC-Auto FIT for screening share. Both companies target the same patient population, payors, and healthcare systems for noninvasive CRC screening.
- QuidelOrtho: QuidelOrtho markets the Triage family of rapid cardiac biomarker tests used in emergency settings, directly competing with PATHFAST for near-patient troponin and BNP testing. Both companies focus on rapid immunoassays and point-of-care diagnostics.
Others
- Eiken Chemical: Eiken Chemical is the originator of the OC-Auto FIT latex agglutination fecal immunochemical test technology and is the manufacturer of the analyzers Polymedco distributes. The relationship is a technology/licensing partnership rather than direct competition in Polymedco's licensed markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Polymedco social profiles
Digital presencePolymedco financial estimates
Financial estimateRevenue estimate
Valuation estimate
Polymedco leadership team
Management profileNumber of profiles
Profiles8 records
Polymedco funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Polymedco M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Polymedco
What does Polymedco do?
Polymedco develops, manufactures, and sells clinical diagnostic test kits and analyzers focused on early detection of life-threatening diseases. Its core offerings are the OC-Auto FIT family of automated fecal immunochemical testing analyzers and the OC-Light S FIT strip test for colorectal cancer screening, the PATHFAST benchtop analyzer and hs-cTnI-II assay for point-of-care cardiac biomarker testing, plus ESR readers (SEDITEN, SEDIMAT 15 Plus) and the BTA stat bladder cancer test. The company bundles these products with customizable programmatic screening services including training, patient education, and direct-to-patient outreach for healthcare systems, payors, providers, reference labs, and emergency departments.
Is Polymedco a public or private company?
Polymedco is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Polymedco founded?
Polymedco was founded in 1980. It employs 101 to 250 people.
Where is Polymedco based?
Polymedco is headquartered in Cortlandt Manor, United States, in the North America region.
How does Polymedco make money?
Three revenue lines are on record. Medical Diagnostic Equipment Sales are the primary driver. The others are diagnostic Reagents and Consumables and programmatic Services.
Who are Polymedco's main competitors?
Broad incumbents on record are Roche Diagnostics, Hologic, Beckman Coulter (Danaher), Siemens Healthineers and Abbott Diagnostics. Direct peers are Guardant Health, Sekisui Diagnostics, Exact Sciences and QuidelOrtho. Eiken Chemical is listed as an others.
Does Polymedco have an API?
No public API is recorded for Polymedco.
What industry is Polymedco in?
Polymedco's product category is In Vitro Clinical Diagnostics. Its primary akta.pro industry code is HLAAALAE, Oncology Diagnostics (tumor profiling, MRD, liquid biopsy), with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 62151 and its SIC code is 8071.